XOMA
NASDAQ · Biotechnology
Xoma Royalty Corporation
$40.17
-4.05 (-9.16%)
Analyst Consensus
Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
-0.4% upside
Low Target
$30.13
Average Target
$40.02
High Target
$66.99
Current Price
$40.17
Current
$40.17
$40.17
Target
$40.02
$40.02
$30.13
$40.02 avg
$66.99
Scenario Analysis
Bear Case
$30.13
-25.0%
Low target
Base Case
$40.02
-0.4%
Avg target
Bull Case
$66.99
+66.8%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$45.22
-11.2% from high
52-Week Low
$22.29
+80.2% from low
Target vs 52W High
$40.02
-11.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |